• Tel: 858.663.9055
  • SeparatorEmail: info@nsjbio.com
  • Tel: 858.663.9055
  • Email: info@nsjbio.com
Home >> Antibodies >> Recombinant PSMA Antibody / Prostate-specific membrane antigen / FOLH1

Recombinant PSMA Antibody / Prostate-specific membrane antigen / FOLH1 [clone RM327] (R20352)

  Catalog No Formulation Size Price (USD)  
Image R20352-0.1ML Antibody in PBS with 50% glycerol, 1% BSA and 0.09% sodium azide 100 ul 419
Microvalidated Recrabbitmono
Bulk quote request
Western blot testing of human LNCaP cell lysate with recombinant PSMA antibody at 1:1000. Predicted molecular weight ~100 kDa.
IHC staining of FFPE human prostate cancer tissue with recombinant PSMA antibody at 1:1000.
Availability 1-3 business days
Species Reactivity Human
Format Purified
Clonality Recombinant Rabbit Monoclonal
Isotype Rabbit IgG
Clone Name RM327
Purity Protein A purified from animal origin-free supernatant
UniProt Q04609
Localization Cytoplasmic, cell surface
Applications Immunohistochemistry (FFPE) : 1:500-1:1000
Western blot : 1:1000-1:2000
Limitations This recombinant PSMA antibody is available for research use only.
Review this product on BioCompare and get a $20 Amazon gift card

Related Products

Description

This antibody reacts to human PSMA (Prostate-specific membrane antigen), also called FOLH1 (Folate Hydrolase 1).

Application Notes

The stated application concentrations are suggested starting points. Titration of the recombinant PSMA antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Immunogen

A peptide corresponding to the C-terminus of human Prostate-specific membrane antigen was used as the immunogen for the recombinant PSMA antibody.

Storage

Store the recombinant PSMA antibody at -20oC.

Cross
Bulk Quote Request Form
Name*:
Organization*:
Email*:
Phone Number*:
Catalog No.*:
Comments and Specifics(amount, formulation, etc.)*:
Validation code: Captchapackage Image


Can't read the image? click here to refresh.
    *required field

Your bulk quote request has been submitted successfully!

Please contact us if you have any questions.